Sustained Disease Control With Aflibercept 8 Mg: A Turning Point in the Management of Exudative Retinal Disease: Expert Consenus. Ukr. j. ophthalmol. 2026, No. 2, 71-76. https://doi.org/10.31288/Ukr.j.ophthalmol.202627176.